Skip to main content
The Cochrane Database of Systematic Reviews logoLink to The Cochrane Database of Systematic Reviews
. 2021 Nov 4;2021(11):CD010504. doi: 10.1002/14651858.CD010504.pub2

Drugs improving insulin resistance for non‐alcoholic fatty liver disease and/or non‐alcoholic steatohepatitis

Nicolas Goossens 1,, Graziella Isgro 2, Francesco Negro 1
Editor: Cochrane Hepato-Biliary Group
PMCID: PMC8568337

Reason for withdrawal from publication

The protocol is out of date. The authors have abandoned the review.

withdrawn

The editorial group responsible for this previously published document have withdrawn it from publication.

History

Protocol first published: Issue 4, 2013
Review first published: Issue 1, 2007

Date Event Description
25 March 2013 New citation required and major changes The authors rewrote the background section of the protocol prepared earlier by Angelico 2006, expanded types of studies, and expanded and changed the inclusion criteria. The review will also include patients with diabetes. Text on concomitant interventions and combination therapy was also added. The types of outcomes were modified in accordance with updated guidelines in the Handbook, ie, modified primary outcomes (added adverse events, quality‐of‐life measures, added details to hepatic‐related morbidity) and secondary outcomes (histological response, radiological response moved here). The search methods were updated and the search strategies were rewritten. Data collection and analysis were also rewritten in accordance to the Higgins 2011 and The Cochrane Hepato-Biliary Group guidelines.
26 July 2012 Amended New team of authors.

Sources of support

Internal sources

  • No sources of support provided

External sources

  • No sources of support provided

Withdrawn from publication for reasons stated in the review


Articles from The Cochrane Database of Systematic Reviews are provided here courtesy of Wiley

RESOURCES